関連する実験動画
Updated: Sep 9, 2025
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.8K
拡張性心筋病における血清Foxc2のダウンレギュレーション:疾患の重症度および心臓機能との関連
Yufu Cai1,2, Qionghui Huang2,3, Shaobin Zhi2,3
1The Fourth Department of Cardiovasular Diseases, Meizhou People's Hospital, Meizhou, Guangdong, P. R. China.
Future science OA
|August 29, 2025
まとめ
血清のFoxc2濃度は,拡張性心筋病 (DCM) の患者で著しく低下しています. Foxc2の低下は心臓機能の低下を示し,主要な心血管疾患 (MACE) のリスクの低下を予測する.
科学分野:
- 心臓病科
- バイオマーカーの発見
- 分子生物学
背景:
- 拡張性心筋病 (DCM) は心不全の主な原因です.
- DCMの病原性におけるFoxc2の役割は十分に理解されていません.
- この研究では,DCMにおける潜在的なバイオマーカーとしてFoxc2を調査しています.
研究 の 目的:
- DCMとDCMでない患者の血清Foxc2レベルを比較する.
- Foxc2と心臓機能とバイオマーカーの相関性を評価する.
- DCMにおけるFoxc2の診断と予後値の評価
主な方法:
- 92人の患者 (53人のDCM,39人の非DCM) の遡及研究.
- 血清Foxc2はELISAで測定した.
- エコーカーディオグラフィのパラメータ,BNP,cTnI,ROC,Kaplan- Meier解析による相関
主要な成果:
- DCM患者では血清Foxc2濃度が有意に低かった (35. 33対77. 51μg/ ml).
- Foxc2は,LVEF/LVFSと正の相関関係があり,LVEDd/BNP/cTnIと負の相関関係がある.
- 高い診断精度 (AUC 0. 862); Foxc2の低下は2年間のMACEリスクの増加を予測した.
結論:
- Foxc2はDCMの診断用バイオマーカーとして可能性を示しています.
- Foxc2は心血管疾患の予後指標として機能する.
- DCMにおけるFoxc2のメカニズム的な役割に関するさらなる研究が必要である.
関連する概念動画
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
27
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
27
01:29Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
01:29Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
01:17Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K